Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search


CHH divests its Tissue and Sancella businesses

Carter Holt Harvey divests its Tissue and Sancella businesses to an international paper company, SCA

Carter Holt Harvey Limited (CHH) today announced it has entered into an agreement to sell its Tissue business and its 50 per cent interest in Sancella to an international paper company, Svenska Cellulosa Aktiebolaget (SCA) for NZ$1,015 billion (AUD$890 m). The agreement is conditional on normal regulatory consents from the Overseas Investment Commission (OIC) and Foreign Investment Review Board (FIRB), with the sale completion date expected to be effective mid May.

The agreement comes after CHH’s November 2003 announcement to explore alternatives for its Tissue business which comprises the Consumer Brands, Experko and Treasures Babycare businesses. The agreement also includes Sancella, a joint venture which manufactures and markets the successful Libra and TENA brands.

CHH Chief Executive Officer, Peter Springford said a key driver for the decision was maximising shareholder value and finding the right ownership option for Tissue. “From the outset we recognised CHH Tissue was a well positioned and maintained business with exceptional brands and a strong market presence. We are delighted with the outcome and the opportunities the new owner can provide CHH Tissue and Sancella employees.

“With a strong international focus in the hygiene products market, SCA has the capacity and resources to develop the offerings of the Tissue and Sancella businesses, helping these businesses to further realise their potential. For SCA, the acquisition delivers strong synergies and value by building on their presence in the important Australasian market,” Mr Springford said.

CHH is in a very strong financial position with a debt to total capitalisation ratio of better than 20 per cent. Taking into account the optimal capital structure and future cash flow, CHH has decided it will distribute approximately half the proceeds but in any event not less than NZ$450 million (AUD$385 million) by way of share buy back, pro rata to all shareholders.

It is anticipated the buy back will take place in CHH’s third quarter, following shareholder approval and the receipt of confirmation from the Inland Revenue Department that the capital return is not a taxable dividend.

SCA President and CEO, Jan Åström said the acquisition was an important step in SCA’s long term strategy.

“We are keen to establish a presence in this market as part of our long term strategy to grow our hygiene products business outside of Europe and North America. The Tissue and Sancella acquisitions will provide a strong basis for this growth and assist SCA to increase its global presence.”

Tissue Chief Operating Officer, Don Matthews will lead SCA Hygiene Australasia as President.

“This is an exciting opportunity for all our Tissue and Sancella employees. As SCA has worked with the Sancella business for the past 25 years (8 years as joint venture partner with CHH), there is already a high level of mutual respect between our organisations. SCA’s hygiene products focus will provide the Tissue and Sancella businesses with benefits and opportunities which may not have been possible under CHH. Its similar culture and commitment to quality and service is an excellent fit for Tissue and Sancella,” Mr Matthews said.

CHH will now focus on its investment in pulp, paper, packaging and wood processing, supported by forests, to consolidate its position as Australasia’s leading wood-fibre processing company.

© Scoop Media

Business Headlines | Sci-Tech Headlines


Voluntary Administration: Renaissance Brewing Up For Sale

Renaissance Brewing, the first local company to raise capital through equity crowdfunding, is up for sale after cash flow woes and product management issues led to the appointment of voluntary administrators. More>>


Approval: Northern Corridor Decision Released

The approval gives the green light to construction of the last link of Auckland’s Western Ring Route, providing an alternative route from South Auckland to the North Shore. More>>


Media Mega Merger: Full Steam Ahead For Appeal

New Zealand's two largest news publishers have confirmed they are committed to pursuing their appeal against the Commerce Commission's rejection of the proposal to merge their operations. More>>

Crown Accounts: $4.1 Billion Surplus

The New Zealand Government has achieved its third fiscal surplus in a row with the Crown accounts for the year ended 30 June 2017 showing an OBEGAL surplus of $4.1 billion, $2.2 billion stronger than last year, Finance Minister Steven Joyce says. More>>


Mycoplasma Bovis: One New Property Tests Positive

The newly identified property... was already under a Restricted Place notice under the Biosecurity Act. More>>

Accounting Scandal: Suspension Of Fuji Xerox From All-Of-Government Contract

General Manager of New Zealand Government Procurement John Ivil says, “FXNZ has been formally suspended from the Print Technology and Associated Services (PTAS) contract and terminated from the Office Supplies contract.” More>>